The GLP-1 Muscle Defense Protocol: Combining Ketosis and Corrective Strength
The defining health challenge of 2026 is not weight loss; it is muscle preservation. While GLP-1 agonists (Semaglutide/Tirzepatide) effectively reduce mass, up to 40% of that loss is lean tissue. The solution is a synergistic protocol combining Low-Energy Ketogenic Therapy (LEKT) to biochemically spare amino acids, and Corrective Strength Training to mechanically signal retention. At…